Once Daily Evening Dosing of Mometasone Furoate Dry Powder Inhaler 200 [mu]g is Effective in Patients with Moderate Persistent Asthma

Methods A randomized, double-blind, placebo-controlled study enrolled patients (>=12 y) who had asthma for at least 6 months and were previously maintained on inhaled corticosteroid (ICS) therapy.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S156
Main Authors: Ramsdell, JW, Bensch, GW
Format: Article
Language:English
Subjects:
Asthma
Drug therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods A randomized, double-blind, placebo-controlled study enrolled patients (>=12 y) who had asthma for at least 6 months and were previously maintained on inhaled corticosteroid (ICS) therapy.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.574